NYSE: ABT
Abbott Laboratories Earnings & Revenue

ABT past earnings growth

How has ABT's earnings growth performed historically?
Company
6.71%%
Industry
23.48%%
Market
48.36%%
ABT's earnings have grown slower (-10.22%% per year) than the US Medical Devices industry average (15.73%%)
Performance
ABT's earnings have grown slower (-10.22%% per year) than the US market average (42.66%%)
Performance
ABT's earnings growth is accelerating - its growth over the last year (6.71%%) is above its 5-year compound annual rate (-10.22%%)
Performance

ABT past revenue growth

How has ABT's revenue growth performed historically?
Company
1.65%%
Industry
6.71%%
Market
14.24%%
ABT's revenue has grown slower (8.93%% per year) than the US Medical Devices industry average (17.37%%)
Performance
ABT's revenue has grown slower (8.93%% per year) than the US market average (16.09%%)
Performance
ABT's revenue growth is slowing down - its growth over the last year (1.65%%) is below its 5-year compound annual rate (8.93%%)
Performance

ABT earnings and revenue history

Current Revenue
$31.4B
Current Earnings
$3.1B
Current Profit Margin
9.9%%
ABT's has not demonstrated consistent long-term earnings growth over the past 10 years (-48.98%%)
Performance

ABT Return on equity

Current Company
10%%
Current Industry
11.5%%
Current Market
-36.3%%
ABT's Return on Equity (10%%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ABT Return on assets

Current Company
4.6%%
Current Industry
6%%
Current Market
6.2%%
ABT is generating lower Return on Assets (4.6%%) than the US Medical Devices industry average (6.14%%)
Performance

ABT Return on capital employed

Current Company
7.14%%
Current Industry
5.3%%
ABT has gotten more efficient at generating Return on Capital (7.14%%) compared to 3 years ago (3.95%%)
Performance

Abbott Laboratories Earnings & Revenue FAQ

On Apr 16, 2020, Abbott Laboratories (NYSE: ABT) reported Q1 2020 earnings per share (EPS) of $0.32, up 15.79%% year over year. Total Abbott Laboratories earnings for the quarter were $564.00 million. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.38.
On Apr 16, 2020, Abbott Laboratories (NYSE: ABT) reported Q1 2020 revenue of $7.73 billion up 2.53%% year over year. In the same quarter last year, Abbott Laboratories's revenue was $7.54 billion.
As of Q4 2020, Abbott Laboratories's earnings has grown 6.71%% year over year. This is 16.77 percentage points lower than the US Medical Devices industry earnings growth rate of 23.48%%. Abbott Laboratories's earnings in the past year totalled $3.11 billion.
As of Q4 2020, Abbott Laboratories's revenue has grown 1.65%% year over year. This is 5.06 percentage points lower than the US Medical Devices industry revenue growth rate of 6.71%%. Abbott Laboratories's revenue in the past year totalled $31.44 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics